Literature DB >> 28003987

Biomechanics of the sclera and effects on intraocular pressure.

Xu Jia1, Juan Yu2, Sheng-Hui Liao3, Xuan-Chu Duan1.   

Abstract

Accumulating evidence indicates that glaucoma is a multifactorial neurodegenerative disease characterized by the loss of retinal ganglion cells (RGC), resulting in gradual and progressive permanent loss of vision. Reducing intraocular pressure (IOP) remains the only proven method for preventing and delaying the progression of glaucomatous visual impairment. However, the specific role of IOP in optic nerve injury remains controversial, and little is known about the biomechanical mechanism by which elevated IOP leads to the loss of RGC. Published studies suggest that the biomechanical properties of the sclera and scleral lamina cribrosa determine the biomechanical changes of optic nerve head, and play an important role in the pathologic process of loss of RGC and optic nerve damage. This review focuses on the current understanding of biomechanics of sclera in glaucoma and provides an overview of the possible interactions between the sclera and IOP. Treatments and interventions aimed at the sclera are also discussed.

Entities:  

Keywords:  biomechanics; finite element models; glaucoma; intraocular pressure; sclera

Year:  2016        PMID: 28003987      PMCID: PMC5155000          DOI: 10.18240/ijo.2016.12.21

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  59 in total

1.  Changes in the biomechanical response of the optic nerve head in early experimental glaucoma.

Authors:  Michael D Roberts; Ian A Sigal; Yi Liang; Claude F Burgoyne; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  Modeling individual-specific human optic nerve head biomechanics. Part II: influence of material properties.

Authors:  Ian A Sigal; John G Flanagan; Inka Tertinegg; C Ross Ethier
Journal:  Biomech Model Mechanobiol       Date:  2008-02-27

3.  Remodeling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma.

Authors:  Michael D Roberts; Vicente Grau; Jonathan Grimm; Juan Reynaud; Anthony J Bellezza; Claude F Burgoyne; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

4.  Magic angle-enhanced MRI of fibrous microstructures in sclera and cornea with and without intraocular pressure loading.

Authors:  Leon C Ho; Ian A Sigal; Ning-Jiun Jan; Alexander Squires; Zion Tse; Ed X Wu; Seong-Gi Kim; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-07       Impact factor: 4.799

5.  Scleral birefringence as measured by polarization-sensitive optical coherence tomography and ocular biometric parameters of human eyes in vivo.

Authors:  Masahiro Yamanari; Satoko Nagase; Shinichi Fukuda; Kotaro Ishii; Ryosuke Tanaka; Takeshi Yasui; Tetsuro Oshika; Masahiro Miura; Yoshiaki Yasuno
Journal:  Biomed Opt Express       Date:  2014-04-03       Impact factor: 3.732

6.  Quantitative mapping of collagen fiber orientation in non-glaucoma and glaucoma posterior human sclerae.

Authors:  Jacek K Pijanka; Baptiste Coudrillier; Kimberly Ziegler; Thomas Sorensen; Keith M Meek; Thao D Nguyen; Harry A Quigley; Craig Boote
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Dynamic material properties of the human sclera.

Authors:  Jill A Bisplinghoff; Craig McNally; Sarah J Manoogian; Stefan M Duma
Journal:  J Biomech       Date:  2009-05-09       Impact factor: 2.712

9.  Effects of mechanical stimulation on viscoelasticity of rabbit scleral fibroblasts after posterior scleral reinforcement.

Authors:  Guohui Wang; Weiyi Chen
Journal:  Exp Biol Med (Maywood)       Date:  2012-10

10.  Collagen structure and mechanical properties of the human sclera: analysis for the effects of age.

Authors:  Baptiste Coudrillier; Jacek Pijanka; Joan Jefferys; Thomas Sorensen; Harry A Quigley; Craig Boote; Thao D Nguyen
Journal:  J Biomech Eng       Date:  2015-02-11       Impact factor: 2.097

View more
  7 in total

1.  Computational Modeling of Ophthalmic Procedures: Computational Modeling of Ophthalmic Procedures.

Authors:  William J Foster; Brian W Berg; Steven N Luminais; Amir Hadayer; Shlomit Schaal
Journal:  Am J Ophthalmol       Date:  2022-03-28       Impact factor: 5.488

2.  Changes in Scleral Thickness Following Repeated Anti-vascular Endothelial Growth Factor Injections.

Authors:  Yao Wang; Frcsc Wei Sim; M A Patrick Wang; Rachel Y Oh; Timothy Ratzlaff; Jacob Rullo; Sanjay Sharma
Journal:  J Ophthalmic Vis Res       Date:  2022-04-29

3.  Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis.

Authors:  Wenquan Tang; Feng Zhang; Ke Liu; Xuanchu Duan
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes.

Authors:  Pedro Manuel Baptista; Rita Vieira; André Ferreira; Ana Figueiredo; Isabel Sampaio; Rita Reis; Maria João Menéres
Journal:  Clin Ophthalmol       Date:  2021-03-08

5.  Corneal Hysteresis in Thais and Variation of Corneal Hysteresis in Glaucoma.

Authors:  Kulawan Rojananuangnit
Journal:  Clin Optom (Auckl)       Date:  2021-10-01

6.  Effect of biomechanical properties on myopia: a study of new corneal biomechanical parameters.

Authors:  Fang Han; Mengdi Li; Pinghui Wei; Jiaonan Ma; Vishal Jhanji; Yan Wang
Journal:  BMC Ophthalmol       Date:  2020-11-19       Impact factor: 2.209

7.  Alterations in proteome of human sclera associated with primary open-angle glaucoma involve proteins participating in regulation of the extracellular matrix.

Authors:  Elena N Iomdina; Natalya K Tikhomirova; Alexander M Bessmertny; Marina V Serebryakova; Viktoriia E Baksheeva; Arthur O Zalevsky; Vladislav I Kotelin; Olga A Kiseleva; Sbrui M Kosakyan; Andrey A Zamyatnin; Pavel P Philippov; Evgeni Yu Zernii
Journal:  Mol Vis       Date:  2020-09-02       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.